Development of diabetes mellitus in living pancreas donors and recipients

References

• Dean PG, Kudva YC, Larson TS et al. Posttransplant diabetes mellitus after pancreas transplantation. Am. J. Transplant.8(1), 175–182 (2008).
   PubMed Web of Science ®Google Scholar
• Tyden G, Reinholt FP, Sundkvist G et al. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N. Engl. J. Med.335(12), 860–863 (1996).
   PubMedGoogle Scholar
• Petruzzo P, Andreelli F, McGregor B et al. Evidence of recurrent type I diabetes following HLA-mismatched pancreas transplantation. Diabetes Metab.26(3), 215–218 (2000).
   PubMedGoogle Scholar
• Gruessner RWG. Living donor pancreas transplantation. In: Transplantation of the Pancreas. Gruessner RWG, Sutherland DER (Eds.), Springer-Verlag, New York, NY, USA, 423–440 (2004).
   Google Scholar
• Seaquist ER, Gruessner RWG. Selection and workup. In: Living Donor Organ Transplantation. Gruessner RWG, Benedetti E (Eds). McGraw-Hill, New York, NY, USA, 385–389 (2008).
   Google Scholar
• Gruessner RWG. Morbidity, mortality, and long-term outcome. In: Living Donor Organ Transplantation. Gruessner RWG, Benedetti E (Eds). McGraw-Hill, New York, NY, USA, 398–400 (2008).
   Google Scholar
• Kendall DM, Sutherland DER, Najarian JS et al. Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N. Engl. J. Med.322(13), 898–903 (1990).
   PubMedGoogle Scholar
• Robertson RP. Endocrine function and metabolic outcomes in pancreas and islet transplantation. In: Transplantation of the Pancreas. Gruessner RWG, Sutherland DER (Eds). Springer-Verlag, New York, NY, USA, 441–454 (2004).
   Google Scholar
• Seaquist ER, Robertson RP. Effects of hemipancreatectomy on pancreatic α and β cell function in healthy human donors. J. Clin. Invest.89(6), 1761–1766 (1992).
   PubMedGoogle Scholar
• Seaquist ER, Pyzdrowski K, Moran A et al. Insulin-mediated and glucose-mediated glucose uptake following hemipancreatectomy in healthy human donors. Diabetologia37(10), 1036–1043 (1994).
   PubMedGoogle Scholar
• Seaquist ER, Kahn SE, Clark PM et al. Hyperproinsulinemia is associated with increased β cell demand after hemipancreatectomy in humans. J. Clin. Invest.97(2), 455–460 (1996).
   PubMed Web of Science ®Google Scholar
• Robertson RP, Lanz KJ, Sutherland DER et al. Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation73(5), 736–741 (2002).
   PubMed Web of Science ®Google Scholar
• Robertson RP, Sutherland DER, Seaquist ER et al. Glucagon, catecholamine, and symptom responses to hypoglycemia in living donors of pancreas segments. Diabetes52(7), 1689–1694 (2003).
   PubMedGoogle Scholar
• Gruessner RWG, Sutherland DER, Drangstveit MB et al. Pancreas transplants from living donors: short- and long-term outcome. Transplant Proc.33(1–2), 819–820 (2001).
   PubMedGoogle Scholar
• Butler AE, Janson J, Bonner-Weir S et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes52(1), 102 (2003).
   PubMed Web of Science ®Google Scholar
• Brubaker PL, Drucker DJ. Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology145(6), 2653–2659 (2004).
   PubMed Web of Science ®Google Scholar
• Gruessner RWG. The identical twin transplant experience: recurrence of disease. In: Living Donor Organ Transplantation. Gruessner RWG, Benedetti E (Eds). McGraw-Hill, New York, NY, USA, 412–413 (2008).
   Google Scholar
• Gruessner RWG. Immunology in pancreas transplantation – autoimmune reactivation. In: Transplantation of the Pancreas. Gruessner RWG, Sutherland DER (Eds). Springer-Verlag, New York, NY, USA, 393–397 (2004).
   Google Scholar
• Sutherland DER, Sibley RK, Xu XZ et al. Twin-to-twin pancreas transplantation: Reversal and reenactment of the pathogenesis of Type I diabetes. Trans. Assoc. Am. Phys.97, 80–87 (1984).
   PubMedGoogle Scholar
• Sutherland DER, Goetz FC, Sibley RK. Recurrence of disease in pancreas transplants. Diabetes38(1), 85–87 (1989).
   PubMed Web of Science ®Google Scholar
• Sibley RD, Sutherland DER, Goetz F et al. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab. Invest.53(2), 132–144 (1985).
   PubMed Web of Science ®Google Scholar
• Santamaria P, Nakhleh RE, Sutherland DER et al. Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes41(1), 53–61 (1992).
   PubMed Web of Science ®Google Scholar
• Nakhleh RE, Gruessner RWG, Swanson PE et al. Pancreas transplant pathology. A morphologic, immunohistochemical, and electron microscopic comparison of allogenic grafts with rejection, syngenetic grafts, and chronic pancreatitis. Am. J. Surg. Pathol.15(3), 246–256 (1991).
   PubMedGoogle Scholar
• Gruessner RWG. Immunology in pancreas transplantation. In: Transplantation of the Pancreas. Gruessner RWG, Sutherland DER (Eds). Springer-Verlag, New York, NY, USA, 393–403 (2004).
   Google Scholar
• Bosi E, Bottazzo GF, Secchi A et al. Islet cell autoimmunity in Type I diabetic patients after HLA-mismatched pancreas transplantation. Diabetes38(1), 82–84 (1989).
   PubMedGoogle Scholar
• Dieterle D, Hierl FX, Gutt B et al. Insulin and islet autoantibodies after pancreas transplantation. Transpl. Int.18(12), 1361–1865 (2005).
   PubMedGoogle Scholar
• Lohmann T, Klemm T, Geissler F et al. Islet cell-specific autoantibodies as potential markers for recurrence of autoimmune Type 1 diabetes after simultaneous pancreas–kidney transplantation. Transplant. Proc.34(6), 2249–2250 (2002).
   PubMedGoogle Scholar
• Sundkvist G, Tyden G, Karlsson FA et al. Islet autoimmunity before and after pancreas transplantation in patients with Type I diabetes mellitus. Diabetologia41(12), 1532–1534 (1998).
   PubMedGoogle Scholar
• Esmatjes E, Rodriguez-Villar C, Ricart MJ et al. Recurrence of immunological markers for Type I (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation. Transplantation66(1), 128–131 (1998).
   PubMedGoogle Scholar
• Thivolet C, Abou-Mara S, Martin X et al. Serological markers of recurrent β cell destruction in diabetic patients undergoing pancreatic transplantation. Transplantation69(1), 99–103 (2000).
   PubMedGoogle Scholar
• Braghi S, Bonifacio E, Secchi A et al. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type I diabetes. Diabetes49(2), 218–224 (2000).
   PubMedGoogle Scholar
• Jaeger C, Hering B, Drybert T et al. Islet cell antibodies and glutamic acid decarboxylase antibodies in patients with insulin-dependent diabetes mellitus undergoing kidney and islet-after-kidney transplantation. Transplantation62(3), 424–426 (1996).
   PubMedGoogle Scholar
• Jaeger C, Hering BJ, Hatziagelaki E et al. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression. J. Mol. Med.77(1), 45–48 (1999).
   PubMed Web of Science ®Google Scholar
• Stegall MD, Lafferty KJ, Kam I et al. Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation61(8), 1272–1274 (1996).
   PubMed Web of Science ®Google Scholar
• Eisenbarth GS, Stegall M. Islet and pancreatic transplantation – autoimmunity and alloimmunity. N. Engl. J. Med.335(12), 888–890 (1996).
   PubMed Web of Science ®Google Scholar
• Vendrame F, Pileggi A, Laughlin E et al. Recurrence of Type 1 diabetes after simultaneous pancreas–kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes59(4), 947–957 (2010).
   PubMed Web of Science ®Google Scholar
• Martin-Pagola A, Sisino G, Allende G et al. Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with Type 1 diabetes and recurrence of autoimmunity. Diabetologia51(10), 1803–1813 (2008).
   PubMed Web of Science ®Google Scholar
• Laughlin E, Burke G, Pugliese A et al. Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation. Clin. Immunol.128(1), 23–30 (2008).
   PubMedGoogle Scholar
• Tanaka S, Kobayashi T, Nakanishi K et al. Evidence of primary β-cell destruction by T-cells and β-cell differentiation from pancreatic ductal cells in diabetes associated with active autoimmune chronic pancreatitis. Diabetes Care.24(9), 1661–1667 (2001).
   PubMedGoogle Scholar
• Wang GS, Rosenberg L, Scott FW. Tubular complexes as a source for islet neogenesis in the pancreas of diabetes-prone BB rats. Lab. Invest.85(5), 675–688 (2005).
   PubMedGoogle Scholar
• Bottino R, Criscimanna A, Casu A et al. Recovery of endogenous β-cell function in nonhuman primates after chemical diabetes induction and islet transplantation. Diabetes58(2), 442–447 (2009).
   PubMedGoogle Scholar
• Jarchum I, Nichol L, Trucco M et al. Identification of novel IGRP epitopes targeted in Type 1 diabetes patients. Clin. Immunol.127(3), 359–365 (2008).
   PubMed Web of Science ®Google Scholar